Background/Aims: The optimal management of bleeding peptic ulcer with adherent clot remains controversial. The purpose of this study was to compare clinical outcome between endoscopic therapy and medical therapy. We also evaluated the risk factors of rebleeding in Forrest type IIB peptic ulcer. Methods: Upper gastrointestinal (UGI) bleeding registry data from 8 hospitals in Korea between February 2011 and December 2013 were reviewed and categorized according to the Forrest classification. Patients with acute UGI bleeding from peptic ulcer with adherent clots were enrolled. Results: Among a total of 1,101 patients diagnosed with peptic ulcer bleeding, 126 bleedings (11.4%) were classified as Forrest type IIB. Of the 126 patients with adherent clots, 84 (66.7%) received endoscopic therapy and 42 (33.3%) were managed with medical therapy alone. The baseline characteristics of patients in two groups were similar except for higher Glasgow Blatchford Score and pre-endoscopic Rockall score in medical therapy group. Bleeding related mortality (1.2% vs. 10%; p=0.018) and all cause mortality (3.7% vs. 20.0%; p=0.005) were significantly lower in the endoscopic therapy group. However, there was no difference between endoscopic therapy and medical therapy regarding rebleeding (7.1% vs. 9.5%; p=0.641). In multivariate analysis, independent risk factors of rebleeding were previous medication with aspirin and/or NSAID (OR, 13.1; p=0.025). Conclusions: In patients with Forrest type IIB peptic ulcer bleeding, endoscopic therapy was associated with a significant reduction in bleeding related mortality and all cause mortality compared with medical therapy alone. Important risk factor of rebleeding was use of aspirin and/or NSAID. (Korean J Gastroenterol 2015;66:98-105) 
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재출혈의 예측인자
연구기간 동안 10예(7.9%)에서 재출혈이 있었으며, 아스피 Values are presented as mean±SD, n only, n (%), or median (range). LMWH, low molecular weight heparin; PPI, proton pump inhibitor. a Calculated with admission risk marker: blood urea nitrogen (0, 2, 3, 4, 6 points), hemoglobin value (0, 1, 3, 6 points for men and 0, 1, 6 points for women), systolic blood pressure (0 to 3 points) and other markers such as pulse rate (0 to 1 point), presentation with melena (1 point), presentation with syncope (2 points), hepatic disease (2 points), cardiac failure (2 points). b Calculated with clinical criteria: age (0 to 2 points), shock (0 to 2 points) and comorbidity (0 to 3 points). c Calculated with clinical criteria score plus additional points for endoscopic diagnosis (0 to 2 points) and endoscopic stigmata of recent hemorrhage (0 to 2 points). Table 3) .
다변량 분석에서는 아스피린, 또는 비스테로이드성 소염제
복용력이 있는 경우만이 재출혈의 독립적인 예측인자로 나타 났다( Table 4) .
고 찰 상부위장관 출혈은 소화성 궤양의 가장 흔한 합병증으로

김시혜 등. 혈괴가 부착된 소화성 궤양 출혈 환자에서 치료 효과 비교
The Korean Journal of Gastroenterology Values are presented as n (%). a Ischemic heart disease, metastatic malignancy, peripheral vascular disease, chronic renal failure, congestive heart failure, cerebrovascular accident, hypertension, diabetes mellitus, atrial fibrillation/atrial flutter, hepatic disease. Values are presented as n (%), n only, mean±SD, or median (range). LMWH, low molecular weight heparin. Values are presented as n (%). 색인단어: 소화성 궤양; 출혈; 사망률; 위험인자
